What Jon Lester's Story Can Teach Us About Non-Hodgkin Lymphoma

What was actually made public

On August 31, 2006, the Boston Red Sox announced that Jon Lester, then a 22-year-old rookie pitcher, had been diagnosed with a rare form of non-Hodgkin lymphoma. The Boston Globe reported the next day that his family described it as a treatable form of anaplastic large cell lymphoma.

That is the whole of the medical disclosure. His family did not say what stage the cancer was, and the Globe noted so at the time. No subtype beyond the name was released either.

Lester later wrote about the experience himself, in a first-person piece for CNN in 2013. He described going home to Seattle for treatment at the Fred Hutchinson Cancer Research Center, reaching his five-year mark free of cancer in 2011, and starting the nonprofit NVRQT with his wife Farrah to fund pediatric cancer research. A 2008 Congressional Record floor speech by Representative Adam Smith notes the diagnosis, the chemotherapy, his return to Major League Baseball in 2007, and his closing out the final game of that year's World Series.

Everything below sticks to that record.

What anaplastic large cell lymphoma is

Non-Hodgkin lymphoma is not one disease. It is a large family of cancers that begin in the lymph system, the network of vessels, nodes, and organs that carries immune cells around the body.

Anaplastic large cell lymphoma, or ALCL, sits in the T-cell branch of that family. NCI describes it as a peripheral T-cell lymphoma marked by the CD30 antigen — a protein on the surface of the cancer cells that treatment can be aimed at. Reporting at the time of Lester's diagnosis put ALCL at roughly 1% to 2% of all lymphomas.

Many cases carry a swap of material between chromosomes 2 and 5. That swap builds a fusion protein involving anaplastic lymphoma kinase, shortened to ALK. NCI notes that people whose lymphoma tests positive for ALK tend to be younger, and tend to have better survival than people whose lymphoma is ALK-negative.

Lester's ALK status was never disclosed. It is not knowable from the public record, and guessing at it would not help anyone.

Why his diagnosis took a detour

Lester first complained of back pain. Team officials and his agent initially put it down to a car accident — he had been rear-ended on the way to Fenway Park on August 18, 2006.

The pain did not settle. He was flown back to Boston for testing instead of making a scheduled start, and the Red Sox then said he had enlarged lymph nodes and had been admitted to Massachusetts General Hospital. The lymphoma diagnosis followed.

This is the useful part of the story for most readers. The symptom that led to the answer was not on any list. It was pain that outlasted its explanation.

What treatment involves

Speaking to the Globe in 2006, Dr. Robert Soiffer of the Dana-Farber Cancer Institute described the usual approach: a combination of chemotherapy drugs given every few weeks for four to six months. He said the cancer responds to chemotherapy and is often curable, and that being young worked in Lester's favor.

Treatment has moved since. NCI now reports a randomized trial in 452 people with CD30-positive T-cell lymphoma comparing CHOP — cyclophosphamide, doxorubicin, vincristine, and prednisone — against a regimen swapping vincristine for brentuximab vedotin, an antibody that carries a cell-killing drug directly to CD30. At a median follow-up of about four years, five-year overall survival was 70.1% with the newer combination and 61.0% with CHOP.

Those percentages describe a trial population with a mix of subtypes and ages. They are not a forecast for any one person, and they were not available in 2006.

Symptoms worth a same-week appointment

There is no screening test for lymphoma in people without symptoms, so noticing things matters more than usual. Book a visit if you have:

• A swollen lymph node in the neck, armpit, or groin lasting beyond three or four weeks, particularly a painless, rubbery one that keeps growing.
• Night sweats that leave nightclothes or sheets wet.
• Repeated fevers over 100.4°F (38°C) with nothing infectious to explain them.
• Weight loss over 10% of your body weight across six months without dieting.
• Itching across the whole body with no rash.
• Any pain that persists past a few weeks after the injury you blamed it on has healed.

Fever, drenching night sweats, and unexplained weight loss are known together as B symptoms, and doctors record them because they affect staging.

What this story cannot tell you

• One person's outcome is not a prediction. NCI is explicit that prognosis in non-Hodgkin lymphoma depends on the specific type, the stage, and other factors that differ from person to person.
• Because Lester's stage and ALK status were never made public, his case cannot be matched to any published survival figure at all.
• ALCL is uncommon. Most non-Hodgkin lymphoma is B-cell, and treatment for those types looks different.
• A comeback at elite level is not the benchmark for a good result. Many people finish treatment and return to ordinary work and life, and that counts fully. Our survivorship guide covers what follow-up looks like afterward.
• Nothing here is medical advice or a comment on anyone's current health.

If you want to check which screening tests do exist for you, our free screening check-up tool walks through it in about two minutes. Lymphoma will not be on that list, and understanding why is part of the point.

Sources

• The Boston Globe, "Jon Lester diagnosed with cancer," September 1, 2006: https://www.bostonglobe.com/sports/2006/09/01/jon-lester-diagnosed-with-cancer/t3LY7PSAhQSD2wOfRGWoRN/story.html
• CNN Human Factor, Jon Lester writing in his own words about his diagnosis and recovery, July 17, 2013: https://www.cnn.com/2013/07/17/health/human-factor-jon-lester/index.html
• Congressional Record floor speech, Rep. Adam Smith, "Honoring Jon Lester": https://adamsmith.house.gov/news/floor-speech/honoring-jon-lester
• National Cancer Institute, Peripheral T-Cell Non-Hodgkin Lymphoma Treatment (PDQ), health professional version: https://www.cancer.gov/types/lymphoma/hp/peripheral-t-cell-lymphoma-pdq
• National Cancer Institute, Non-Hodgkin Lymphoma Treatment (PDQ), patient version: https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq

How this page was made

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.

See an error, old source, or unclear wording? Tell us.